Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
50.78
+0.62 (1.24%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Bio-Techne Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Bio-Techne stock have an average target of 81.14, with a low estimate of 68 and a high estimate of 95. The average target predicts an increase of 59.79% from the current stock price of 50.78.
Analyst Consensus: Buy
* Price targets were last updated on Mar 18, 2025.
Analyst Ratings
The average analyst rating for Bio-Techne stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 1 |
| Buy | 4 | 4 | 4 | 2 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $75 | Buy | Initiates | $75 | +47.70% | Mar 18, 2025 |
| Citigroup | Citigroup | Hold Maintains $80 → $70 | Hold | Maintains | $80 → $70 | +37.85% | Mar 4, 2025 |
| Baird | Baird | Buy → Hold Downgrades $88 → $68 | Buy → Hold | Downgrades | $88 → $68 | +33.91% | Feb 19, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $79 → $80 | Hold | Maintains | $79 → $80 | +57.54% | Feb 6, 2025 |
Financial Forecast
Revenue This Year
1.25B
from 1.16B
Increased by 8.19%
Revenue Next Year
1.37B
from 1.25B
Increased by 8.85%
EPS This Year
1.95
from 1.05
Increased by 85.50%
EPS Next Year
2.24
from 1.95
Increased by 15.02%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.3B | 1.4B | 1.6B | ||
| Avg | 1.3B | 1.4B | 1.5B | ||
| Low | 1.2B | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.4% | 14.8% | 18.8% | ||
| Avg | 8.2% | 8.9% | 11.9% | ||
| Low | 3.0% | 2.4% | 3.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.22 | 2.52 | 2.93 | ||
| Avg | 1.95 | 2.24 | 2.57 | ||
| Low | 1.82 | 1.91 | 2.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 111.0% | 29.4% | 30.8% | ||
| Avg | 85.5% | 15.0% | 14.8% | ||
| Low | 73.6% | -1.9% | -4.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.